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ABSTRACT
Induction of heme oxygenase-1 (HO-1) expression has been as-
sociated with cytoprotective and anti-inflammatory actions of lan-
soprazole, a proton pump inhibitor, but the underlying molecular
mechanisms remain largely unresolved. In this study, we investi-
gate the role of transcriptional NF-E2-related factor 2 (Nrf2), its
phosphorylation/activation, and oxidation of Kelch-like ECH-
associating protein 1 (Keap1) in lansoprazole-induced HO-1
up-regulation using cultured gastric epithelial cells (rat gastric
mucosal cell line, RGM-1). HO-1 expression of RGM-1 cells was
markedly enhanced in a time- and dose-dependent manner by the
treatment with lansoprazole, and this up-regulation of HO-1 con-
tributed to the inhibition of chemokine production from stimulated
RGM-1 cells. Transfection of Nrf2-siRNA suppressed the lanso-
prazole-induced HO-1. An electrophoretic mobility shift assay
showed increases in the nuclear translocation and stress-re-
sponse elements (StRE) binding activity of Nrf2 proteins in RGM-1
cells treated with lansoprazole. Furthermore, in RGM-1 cells trans-
fected with HO-1 enhancer luciferase reporter plasmid containing
mutant StRE, lansoprazole-induced HO-1 reporter gene activity
was diminished. Lansoprazole promoted the phosphorylation of
extracellular signal-regulated kinase (ERK), and lansoprazole-in-
duced HO-1 up-regulation was suppressed by U0126, an ERK-
specific inhibitor. Phosphorylated Nrf2 protein was detected in the
phosphoprotein fraction purified by a Pro-Q Diamond Phospho-
protein Enrichment kit. Finally, an oxidative form of the Keap1
protein was detected in lansoprazole-treated RGM-1 cells by an-
alyzing S-oxidized proteins using biotinylated cysteine as a mo-
lecular probe. These results indicate that lansoprazole up-regu-
lates HO-1 expression in rat gastric epithelial cells, and the up-
regulated HO-1 contributes to the anti-inflammatory effects of the
drug. Phosphorylation of ERK and Nrf2, activation and nuclear
translocation of Nrf2, and oxidation of Keap1 are all involved in the
lansoprazole-induced HO-1 up-regulation.
Proton pump inhibitors (PPIs) such as lansoprazole and
omeprazole are extensively used to treat acid-related disor-
ders, including gastroesophageal reflux disease and peptic
ulcer disease caused by stress, nonsteroidal anti-inflamma-
tory drugs, and Helicobacter pylori infection. PPIs are strong
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anti-secretory agents that act on gastric H/K-adenosine
triphosphatase (H/K ATPase) of parietal cells (Fellenius et
al., 1981). In addition to their acid-suppressing effects, PPIs,
especially lansoprazole, have been shown to modulate the
inflammatory status, reduce oxidative stress, and ameliorate
mucosal injuries in the esophagus (Yoshida et al., 2004),
intestine (Ichikawa et al., 2004), and lung (Hendriks et al.,
2001), in addition to the stomach (Becker et al., 2006). It has
been demonstrated by in vitro studies that PPIs inhibit the
increased expression of vascular adhesion molecules, the ac-
tivation of neutrophils, and the production of proinflamma-
tory cytokines (Yoshida et al., 2000; Handa et al., 2004). We
recently demonstrated using in vivo models that lansopra-
zole inhibits acute inflammatory reactions as well as intes-
tinal mucosal injuries induced by ischemia-reperfusion
(Ichikawa et al., 2004). Our recent study using a DNA mi-
croarray clearly showed that lansoprazole induces several
genes, including phase II detoxifying enzyme (NADPH-
ubiquinone oxidoreductase, glutathione S-transferase) and
antioxidant stress proteins [heme oxygenase-1 (HO-1), thi-
oredoxin reductase, and superoxide dismutase) in gastric
epithelial cells (Naito, JCBN2007, http://www2.kpu-m.ac.jp/
%7Efirstmed/GeneChip.html]. Becker et al. (2006) also dem-
onstrated that PPIs protect gastric epithelial cells against
oxidative stress, and this protection is abrogated in the pres-
ence of an HO-1 inhibitor. These data indicate that lansopra-
zole-induced HO-1 induction might account for the cytopro-
tective and anti-inflammatory effects of lansoprazole
independent of acid-secretion inhibition.
Heme oxygenase (HO) is involved in heme catabolism, a
process in which the oxidation of heme leads to the produc-
tion of iron, biliverdin, and carbon monoxide (Maines, 1997).
Three mammalian HO isozymes have been identified, one of
which, HO-1, is a stress-responsive protein. HO-1 is highly
inducible by a vast array of stimuli, including oxidative
stress, heat shock, ultraviolet radiation, ischemia-reperfu-
sion, heavy metals, bacterial lipopolysaccharide (LPS), cyto-
kines, nitric oxide, and its substrate, heme (Shibahara, 1988;
Sassa, 2006). This strong adaptive response of HO-1 to var-
ious stimuli suggests an entirely new paradigm in which
HO-1 could play a significant role in protection against in-
flammatory processes and oxidative tissue injury.
Recent studies have extensively investigated the transcrip-
tional factors and regulatory regions that are responsible for
induction of the ho-1 gene. Several signaling molecules [e.g.,
mitogen-activated protein kinases (MAPKs)] and transcrip-
tional regulators [activator protein-1, NF-E2-related factor 2
(Nrf2), hypoxia-inducible factor-1, Bach-1] participate in the
regulation of the ho-1 gene. In these molecules, accumulating
data implicate Nrf2 as a key regulator of the adaptive re-
sponse to oxidative stress (Alam et al., 1999; Itoh et al., 1999;
Ishii et al., 2000; Itoh et al., 2003) and of the transcriptional
activation of ho-1 (Ryter and Choi, 2005).
Under normal conditions, Nrf2 localizes in the cytoplasm,
where it interacts with the actin-binding protein, Kelch-like
ECH-associating protein 1 (Keap1), and is rapidly degraded
by the ubiquitin-proteasome pathway (Sekhar et al., 2002).
Namely, Keap1 acts as negative regulator of Nrf2. Various
stimuli, including electrophiles and oxidative stress, liberate
Nrf2 from Keap1, allowing Nrf2 to translocate into the nu-
cleus and to bind to stress- or antioxidant-response elements
(He et al., 2001). Nuclear translocation of Nrf2 provides im-
mediate transactivation of regulated encoding genes. In this
sequence of Nrf2 activation, the phosphorylation of Nrf2 is an
important event in the dissociation of Nrf2 from Keap1
(Bloom and Jaiswal, 2003; Numazawa et al., 2003). Further-
more, it has been demonstrated that the oxidation of Keap1
causes a change in the affinity of Keap1 with Nrf2, easily
releasing Nrf2 (Dinkova-Kostova et al., 2002).
Thus, the Nrf2-Keap1 system is considered as a major
defense mechanism that plays a key role in the induction of
HO-1. However, it remains unclear whether lansoprazole is
involved in the Nrf2-Keap1 system, or in the subsequent
induction of HO-1, which is a potent anti-inflammatory en-
zyme. In the present study, we investigated the molecular
mechanism of the anti-inflammatory action of lansoprazole
mainly by using cultured gastric epithelial cells. In the anal-
ysis of the up-regulation of HO-1 by lansoprazole, we focused
on the involvement of lansoprazole in the activation and
phosphorylation of Nrf2 and oxidation of Keap1.
Materials and Methods
Materials. Lansoprazole (2-([3-methyl-4-(2,2,2-trifluoroethoxy)-
pyridin-2-yl]methylsulfinyl)-1H-benzo[d]imidazole), a kind gift from
Takeda Chemical Industries (Osaka, Japan), was dissolved in etha-
nol and the following experiments were performed as final concen-
tration of ethanol was 0.5%. Omeprazole was obtained from Wako
Pure Chemical (Osaka, Japan) and famotidine was obtained from
Sigma-Aldrich Japan K.K. (Tokyo, Japan). The following inhibitors
were used: Tin-protoporphyrin as an HO-1 inhibitor [tin-protopor-
phyrin (SnPP); Sapphire Bioscience Pty., Ltd., Redfern, Australia],
mitogen-activated protein kinase kinase 1/2 inhibitor as an extracel-
lular signal-regulated kinase (ERK) inhibitor (U0126; BIOMOL In-
ternational LP, Plymouth Meeting, PA), p38 MAPK inhibitor
(SB203580; BIOMOL International LP), and Jun N-terminal kinase
(JNK) inhibitor (SP600125; BIOMOL International LP). Rabbit poly-
clonal anti-HO-1 antibody was purchased from Assay Designs (Ann
Arbor, MI). The antibodies of p44/42, phosho-p44/42, p38, phosho-
p38, JNK, and phosho-JNK were products of Cell Signaling Technol-
ogy Inc. (Danvers, MA). Rabbit polyclonal anti-Keap1 antibody was
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). All
other chemicals were of the highest quality commercially available.
Gastric Epithelial Cell Line. The rat gastric mucosal cell line
RGM-1 (RCB-0876 at the Riken Cell Bank, Tsukuba, Japan), estab-
lished by Matsui and Ohno, was used (Kobayashi et al., 1996).
RGM-1 cells have the characteristics of gastric mucous-producing
cells, and they have prostaglandin EP4 receptors (Kobayashi et al.,
1996) and do not express parietal cell-specific H, K-ATPase (Shi-
mokawa et al., 2007). RGM-1 cells were grown in a 1:1 mixture of
Dulbecco’s modified Eagle’s medium and Ham’s F12 medium supple-
mented with 10% heat-inactivated fetal bovine serum, 2 mM glu-
tamine, 100 U/ml penicillin, 100 g/ml streptomycin, and 0.25 g/ml
amphotericin. The cells were incubated at 37°C in a humidified
atmosphere with 5% CO2. For the experiments, RGM-1 cells were
trypsinized and seeded into 96-well cell culture plates or 8-well
chamber glass slides. Experiments were performed when the cells
were confluent.
Enzyme-Linked Immunosorbent Assay. RGM-1 cells were cul-
tured in 96-well plates until confluent and stimulated with or with-
out interleukin (IL)-1 (1 ng/ml; Genzyme-Techne, Cambridge, MA)
and/or lansoprazole (10 M) and/or an HO-1 inhibitor, SnPP (1 M),
for 6 h. Cytokine-induced neutrophil chemoattractant-1 (CINC-1)
production (release in culture supernatants) was assessed by using
an enzyme-linked immunosorbent assay (ELISA) kit (Immunobio-
logical Laboratories, Gunma, Japan) according to the manufacturer’s
instructions. In brief, 100 l of cell supernatants was placed into
96-well plates coated with rabbit anti-rat growth-regulated oncogene
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(GRO)/CINC-1 IgG and incubated for 1 h at room temperature. The
supernatants were then removed, and the wells were washed with
1% bovine serum albumin and 0.05% Tween 20 in phosphate-buff-
ered saline (PBS). Subsequently, horseradish peroxidase (HRP)-con-
jugated rabbit-anti rat GRO/CINC-1 antibody (Fab fragments) was
added, and the amount of CINC-1 was determined colorimetrically
30 min later (490-nm wavelength; MPR-A4i microplate reader;
Tosoh, Tokyo, Japan) using tetra methyl benzidine as a substrate.
RNA Analysis. The mRNA expression of ho-1, nrf2, and -actin
as an internal control was determined by real-time polymerase chain
reaction (PCR). Total RNA was isolated from intestinal mucosal
tissue by the acid guanidinium phenol chloroform method with an
Isogen kit (Nippon Gene Co., Ltd., Toyama, Japan), and the concen-
tration of RNA was determined by absorbance at 260 nm in relation
to that at 280 nm. The isolated RNA was stored at 70°C until used in
real-time PCR. For the real-time PCR, 1 g of extracted RNA was
reverse-transcribed into first-strand cDNA at 42°C for 40 min, using
200 U of M-MLV reverse-transcriptase (Promega, Madison, WI) and
0.5 g of oligo(dT) 15 primer (Takara Bio Inc., Shiga, Japan) in a
20-l reaction mixture. Real-time PCR for ho-1, nrf2, and -actin
was carried out with a 7300 Real-Time PCR system (Applied Biosys-
tems, Foster City, CA) using the DNA-binding dye SYBR Green I for
the detection of PCR products. The reaction mixture contained 12.5
l of Premix Ex Taq and 0.5 l of ROX reference dye (Code RRO41A;
Takara Bio Inc.), 1 l of custom-synthesized primers, and 2 l of
cDNA (equivalent to 20 ng of total RNA) to give a final reaction
volume of 25 l. The PCR settings were as follows: the initial dena-
turation for 15 s at 95°C was followed by 40 cycles of amplification for
15 s at 95°C and 31 s at 60°C, with subsequent melting curve
analysis in which the temperature was increased from 60 to 95°C.
The primers had the following sequences: for ho-1, sense 5-CAAC-
CCCACCAAGTTCAAACA-3 and antisense 5-AGGCGGTCTTAGC-
CTCTTCTG-3; for nrf2, sense 5-CCGCCTGGGTTCAGTGACT-3
and antisense 5-GCTTTAGGTCCATTCTGTTTGACA-3; and for
-actin, sense 5-GAGCAAACATCCCCCAAAGTT-3 and antisense
5-GCCGTGGATACTTGGAGTGACT-3. Relative quantification of
gene expression with real-time PCR data were calculated relative to
-actin.
Western Blotting. Total proteins were mixed with SDS sample
buffer. The samples were subjected to a 12% SDS-polyacrylamide gel
electrophoresis (PAGE) and blotted onto a polyvinylidene difluoride
(PVDF) membrane (Atto Corporation, Tokyo, Japan). The membrane
was blocked with 2% bovine serum albumin in TBS-T (TBS and 0.1%
Tween 20) at room temperature for 30 min. Western blotting was
carried out using rabbit polyclonal anti-HO-1 antibody (1:1000 dilu-
tion in TBS-T), rabbit polyclonal anti-p44/42, phosho-p44/42, p38,
phosho-p38, JNK, and phosho-JNK (1:1000) at room temperature for
1 h. After three washes with TBS-T, the membrane was incubated
with anti-rabbit IgG-HRP (1:3000; GE Healthcare UK, Ltd., Chal-
font St. Giles, UK) at room temperature for 45 min. The signals were
visualized using an enhanced chemiluminescence (ECL) kit (GE
Healthcare UK, Ltd.) according to the manufacturer’s instructions.
The band intensities were determined using CS Analyzer software,
version 2.0 (Atto Corporation).
The Localization of HO-1. Confluent RGM-1 cultured on Lab
Tek chamber slides were preincubated with or without lansoprazole
(10 M) for 6 h. The cells were then washed with PBS and stained
with rabbit polyclonal anti-HO-1 antibody (Stressgen Bioreagents)
and AlexaFluoro 488-labeled goat anti-rabbit IgG antibody (Invitro-
gen, Carlsbad, CA). The expression of HO-1 was observed under a
confocal laser scanning microscope (FV1000; Olympus, Tokyo, Ja-
pan) using sequential activation. Photographic images were taken
from four random fields.
Blocking of Nrf2. Nrf2-small interfering RNA (siRNA) and con-
trol-siRNA (a nontargeting siRNA; Santa Cruz Biotechnology) were
transfected using the siRNA transfection reagent according to the
manufacturer’s protocol. The sequences of Nrf2-siRNA oligonucleo-
tides were as follows: sense, 5-CGCUCAGAACUGUAGGAAAA
GGAAG-AG-3 and antisense, 5-UA-GCGAGUCUUGACAUCCU-
UUUCCUUC-5. In RGM-1 transfected with Nrf2-siRNA or control-
siRNA, the expression of the HO-1 gene and protein by lansoprazole
treatment were investigated using real-time PCR and Western blot-
ting. Nrf2(/) and Nrf2(/) (wild type) fibroblasts were described
previously (Wakabayashi et al., 2003). As stated above, the expres-
sion of the HO-1 gene and protein by lansoprazole treatment were
checked.
Electrophoretic Mobility Shift Assay for Nrf2. By using elec-
trophoretic mobility shift assay (EMSA), we assessed lansoprazole-
induced Nrf2 binding activity in RGM-1 cells. Cells were cultured in
10-cm cell culture dishes. RGM-1 cells were preincubated with or
without lansoprazole for 2 h. The medium was then removed and the
cells were washed twice with PBS. Nuclear protein fractions were
extracted as described previously (Cepinskas et al., 2003). For
EMSA, 5 g of total extracted nuclear proteins was incubated with 1
pmol double-stranded [32P]ATP end-labeled oligonucleotide probe
containing the core stress-responsive DNA element (StRE) se-
quences (Alam and Cook, 2003) (sense strand, 5-TTTTCTGCT-
GAGTCAAGGTCCG-3; antisense strand, 3-AAAAGACGACT-
CAGTTCCAGGC-5) in binding buffer (10 mM HEPES, pH 7.9, 80
mM NaCl, 3 mM MgCl2, 0.1 mM EDTA, 1 mM dithiothreitol, 1 mM
phenylmethylsulfonyl fluoride, and 10% glycerol). After electro-
phoresis under nondenaturing conditions (0.5 TBE buffer), the gels
were dried and radioactive bands were visualized on X-ray films. In
the supershift assays, nuclear extracts were incubated with 1 g of
rabbit polyclonal anti-Nrf2 antibody (Santa Cruz Biotechnology) for
1 h after addition of probe.
Plasmid Preparation and Transient Transfection Assay. A
total of 188 base pairs of mouse HO-1 E2 enhancer was PCR-ampli-
fied with the primers (5-AAA GGT ACC GCA GCC AGG GCA
GTC-3 and 5-AAA GAG CTC CCA GCA CGT CCG CTC-3) and
cloned into KpnI and SacI sites of pRBGP3 plasmid (Igarashi et al.,
1994). To make mutant HO-1 enhancer luciferase reporter, all three
StRE elements (5-GCTGAGTCA-3) in E2 enhancer were mutated
to 5-AATGAGTCA-3 by PCR-based mutagenesis using PfuUltra
High-Fidelity DNA polymerase (Stratagene, La Jolla, CA). For re-
porter assay, RGM-1 cells were transfected using TransFast Trans-
fection Reagent (Promega) according to the manufacturer’s instruc-
tions. The luciferase assay was performed with the Dual-Luciferase
Reporter Assay Kit (Promega) following the supplier’s protocol and
measured in a Biolumat Luminometer (Berthold Technologies
GmbH and Co. KG, Bad Wildbad, Germany). Transfection efficien-
cies were routinely normalized to the activity of a cotransfected
Renilla luciferase. The means of five independent experiments were
presented with the S.E.M.
Isolation of Phosphoproteins from Cellular Extracts.
RGM-1 cells were preincubated with or without lansoprazole for 2 h.
Isolation of phosphoproteins from cellular extracts was carried out
using a Pro-Q Diamond Phosphoprotein Enrichment Kit (Invitrogen
Detection Technologies) according to the manufacturer’s protocol. In
brief, 1 mg of cellular extracts was prepared using lysis buffer (8 M
Urea, 30 mM Tris-HCl, 4% CHAPS, pH 8.5), then supplemented with
a Protease Inhibitor and Endonuclease Module (20 l/1 ml protease
inhibitor, 10 l/1 ml endonuclease; Invitrogen Detection Technolo-
gies). After 30 min on ice, the cellular extracts were diluted with 5 ml
of washing buffer and applied to a column containing 1 ml of resin,
and the flow-through was saved for analysis of the unphosphorylated
proteins. After washing the column with washing buffer, bound
proteins were eluted with 250 l of elution buffer. The elution step
was repeated five times. The eluate and the flow-through were
concentrated until the sample volume was reduced to approximately
50 l using Vivaspin filtration concentrators with a 10 kDa cutoff
polyethersulfone membrane. A solution of 25 mM Tris, pH 7.5, and
0.25% CHAPS was then added to the retentate reservoir, and the
sample was concentrated to a volume of approximately 50 l. The
samples were precipitated using the methanol-chloroform-water
method. The precipitated samples were dissolved in 50 l of lysis
HO-1 Up-Regulation by Lansoprazole 257
buffer (8 M Urea, 30 mM Tris-HCl, 4% CHAPS, pH 8.5). The super-
natants were recovered by centrifugation at 15,000g for 5 min and
separated on a 12% SDS-PAGE, and the gel was stained with Pro-Q
Diamond phosphoprotein gel stain (Invitrogen) and Sypro ruby gel
stain (Invitrogen).
Analysis of S-Oxidized Proteins. The cells were incubated with
100 M biotin-cysteine for 15 min as described previously (Ishii and
Uchida, 2004). The cells were then washed twice with PBS and
stimulated with 10 M lansoprazole. Finally, the cells were lysed in
lysis buffer and centrifuged at 10,000 rpm for 10 min at 4°C, and the
supernatants were stored at 80°C until use. For detection of the
S-oxidized proteins, these samples were mixed with SDS sample
buffer, separated by 10% SDS-PAGE, and blotted onto a PVDF
membrane. The membrane was blocked, washed, and incubated with
the Streptavidin-HRP conjugate (GE Healthcare). This procedure
was followed by the addition of ECL reagents, and then the mem-
brane was visualized.
Subsequently, to confirm the oxidation of the Keap1 protein, the
cells were incubated with 100 M biotin-cysteine for 15 min, washed
twice with PBS, and stimulated with 10 M lansoprazole for 45 min.
The cells were lysed in lysis buffer and centrifuged at 10,000 rpm for
10 min at 4°C, and the supernatants were stored. To isolate the
biotin-cysteine modified protein, the samples were mixed with
Streptavidin MicroBeads (Miltenyi Biotec K.K., Tokyo, Japan), and
the MicroBeads-labeled proteins were separated using  Columns
(Miltenyi Biotec K.K.). The collected samples were mixed with SDS
sample buffer and separated by 10% SDS-PAGE and then blotted
onto a PVDF membrane. The membrane was blocked, washed, and
incubated with rabbit polyclonal anti-Keap1 antibody (1:500; Santa-
Cruz Biotechnology) at room temperature for 1 h. After three washes
with TBS-T, the membrane was incubated with anti-rabbit IgG-HRP
(GE Healthcare). This procedure was followed by the addition of ECL
reagents, and then the membrane was visualized.
Statistical Analysis. The results are presented as the mean 
S.E.M. An overall difference between the groups was determined by
one-way analysis of variance. If the one-way analysis of variance was
significant, the differences between individual groups were analyzed
by Tukey’s multiple comparison test. Values of P  0.05 were con-
sidered statistically significant. All analyses were performed using
the program GraphPad Prism 4 (GraphPad Software Inc., San Diego,
CA) on a Macintosh computer.
Results
Lansoprazole Up-Regulated HO-1. To test the expres-
sion of HO-1 induced by lansoprazole, we checked the HO-1
gene and protein expression using real-time PCR and West-
ern blotting. Lansoprazole (10 M) stimulation significantly
increased the expression of the ho-1 gene in RGM-1 cells in a
time-dependent manner (Fig. 1A). In association with the
increased ho-1 gene expression, the expression of the HO-1
protein was also increased in a time-dependent manner with
a peak at 6 h (Fig. 1B), and the increase in the HO-1 protein
was dependent on the concentration of lansoprazole (Fig. 1C).
The localization of HO-1 in RGM-1 cells in response to lan-
soprazole was also assessed using confocal microscopy. A
strong expression of HO-1 in the cytoplasm of RGM-1 cells
was induced 6 h after the stimulation of RGM-1 cells with
lansoprazole (Fig. 1D). Furthermore, we checked whether
another anti-acid secretory agent also induced the expression
of HO-1. As a result, omeprazole, another PPI, and famoti-
dine, H2-receptor antagonists induced the faint expression of
HO-1 compared to HO-1 expression induced by lansoprazole
(Fig. 1E).
Lansoprazole-Induced HO-1 Up-Regulation Contrib-
uted to the Inhibition of Chemokine Production from
Gastric Mucosal Cells. Our previous report demonstrated
that rat gastric epithelial cells (RGM-1 cells) produced
CINC-1 in response to various proinflammatory cytokines,
such as tumor necrosis factor-	, IL-1, and bacterial LPS. To
confirm the anti-inflammatory effect of lansoprazole-induced
HO-1 on RGM-1 cells, we measured the production of CINC-1
on RGM-1 cells using ELISA. As shown in Fig. 2, proinflam-
matory cytokines (IL-1, 1 ng/ml) significantly increased the
production of CINC-1 by RGM-1 cells after 6 h of stimulation.
Fig. 1. Up-regulation of HO-1 by lan-
soprazole in RGM-1 cells. RGM-1 cells
were incubated with lansoprazole. A,
ho-1 gene expression was measured
using real-time PCR. The mRNA level
of -actin was determined simulta-
neously, and HO-1/-actin ratio was
calculated for each sample. Values
represent the mean  S.E.M. (n 
 6).
#, p  0.05 and , p  0.01 compared
to no stimulation (0 h). B and C,
whole-cell extracts were prepared and
analyzed by immunoblotting with an
antibody against HO-1. D, the expres-
sion and the localization of HO-1 in
RGM-1 cells 6 h after lansoprazole
treatment was investigated using con-
focal microscopy. E, omeprazole, an-
other PPI, and famotidine, H2-recep-
tor antagonists induced the faint
expression of HO-1 compared to HO-1
expression induced by lansoprazole.
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Unstimulated RGM-1 cells produced a small amount of
CINC-1 during the same period of time. The increased pro-
duction of CINC-1 by IL-1 was significantly inhibited with
lansoprazole (10 M) treatment. This inhibition was dimin-
ished by simultaneous treatment with SnPP, an HO-1 inhib-
itor (Fig. 2). The concentration of SnPP used in the experi-
ment did not affect the CINC-1 production in unstimulated
cells. Based on a previous report (Shokawa et al., 2006;
Canas et al., 2007), the concentration used was sufficient to
specifically inhibit HO activity. On this basis, the results in
Fig. 2 show that up-regulation of HO-1 by lansoprazole con-
tributes to the inhibition of chemokine production from stim-
ulated gastric mucosal cells.
Role of Nrf2 in HO-1 Up-Regulation by Lansoprazole.
An siRNA approach was used to determine whether lanso-
prazole-mediated up-regulation of HO-1 was dependent on
Nrf2. RGM-1 cells were transiently transfected with either
control siRNA or siRNA directed against Nrf2. Thirty hours
after transfection, cells were exposed to lansoprazole for 6 h,
and then ho-1 mRNA and HO-1 protein expression were
examined by real-time PCR and Western blotting, respec-
tively. Real-time PCR analysis revealed that treatment with
siRNA oligonucleotides led to a 51% reduction in the nrf2
mRNA level in RGM-1 cells 30 h after transfection (Fig. 3A).
Under these conditions, ho-1 mRNA expression by lansopra-
zole stimulation was significantly decreased in comparison
with that in the control siRNA (Fig. 3B). In cells transfected
with control siRNA, lansoprazole also produced an increase
in the HO-1 protein expression. The intensity of the HO-1-
immunoreactive band was measured and expressed relative
to the expression of actin (Fig. 3D). Transfection of siRNA
directed against Nrf2 suppressed the lansoprazole-induced
expression of HO-1 by 71%. Moreover, to reaffirm that Nrf2
plays a role in the HO-1 expression induced by lansoprazole,
we tested the effects of lansoprazole on the expression of
HO-1 in Nrf2(/) and Nrf2(/) fibroblasts, because the
efficacy of nrf2 mRNA reduction by Nrf2 siRNA in RGM-1
cells was not as good as expected. In Nrf2(/) fibroblasts,
lansoprazole up-regulated ho-1 mRNA and HO-1 protein ex-
pression at the concentration of 100 M (Fig. 4A). As shown
in Fig. 4B, ho-1 mRNA expression was faint in Nrf2(/)
fibroblasts with or without lansoprazole incubation. Immu-
noblotting showed that the expression of HO-1 protein was
Fig. 2. The inhibition of CINC-1 production in RGM-1 cells treated with
lansoprazole. RGM-1 cells were stimulated with or without IL-1 (1
ng/ml), and/or lansoprazole (10 M) and/or an HO-1 inhibitor, SnPP (1
M) for 6 h. The concentration of CINC-1 in culture supernatant was
determined by an ELISA kit specific for rat CINC-1. Data represent the
mean  S.E. (n 
 3). , p  0.05 compared to the ethanol group. #, p 
0.05 compared to the IL-1 stimulation group.
Fig. 3. The effect of Nrf2-siRNA on
HO-1 expression. RGM-1 cells were
transfected with Nrf2-specific or con-
trol siRNA oligonucleotides by using
the RNAi transfection reagent. There-
after, the cells were stimulated with
lansoprazole for 6 h. The mRNA was
extracted from the cells, and the ex-
pression of Nrf2 (A) and HO-1 (B) was
monitored using real-time PCR. Val-
ues are the mean  S.E.M. -fold
change, considering 1 as the value for
control siRNA samples (n 
 6). , p 
0.05 compared to control-siRNA (A)
and control-siRNA incubated with
lansoprazole (B). Moreover, the pro-
tein was also isolated, immunoblotted
using anit-HO-1 antibody and actin as
internal control (C), and densitomet-
ric analysis (D) was carried out using
the ImageJ software (Wayne Rash-
band; National Institutes of Health,
Bethesda, MD).
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not detectable in Nrf2(/) fibroblasts (Fig. 4B). These ex-
periments demonstrate a direct correlation between Nrf2 and
HO-1 expression and support the contention that lansopra-
zole-mediated up-regulation of HO-1 is Nrf2-dependent.
StRE-Binding Activities in RGM-1 Cells Treated
with Lansoprazole. To analyze the DNA binding activity of
Nrf2, we carried out EMSA with the use of nuclear extracts
from RGM-1 cells with or without lansoprazole treatment. As
shown in Fig. 5A, StRE-binding proteins were detected and
increased with lansoprazole treatment in a dose-dependent
manner (Fig. 5A, arrow). In addition, the complex band that
increased with lansoprazole treatment disappeared with the
addition of anti-Nrf2 polyclonal antibody (Fig. 5B, arrow-
head). These results indicated that one of the StRE-binding
proteins increased by lansoprazole was Nrf2. Lansoprazole
translocated Nrf2 to the nuclear fraction and promoted Nrf2-
DNA binding activities.
HO-1 Enhancer Activity in RGM-1 Cells Treated with
Lansoprazole. To further examine the role of Nrf2 in lan-
soprazole-induced HO-1 gene expression, we performed lucif-
erase reporter assay using HO-1 E2 enhancer-luciferase re-
porter gene in which HO-1 E2 enhancer containing three
StREs was placed upstream of rabbit -globin TATA box and
luciferase gene. We also prepared a mutant enhancer re-
porter gene where all of the three Nrf2 binding sites, but not
overlapping AP-1 binding sites, were mutated (see Materials
and Methods). As shown in Fig. 6A, lansoprazole-induced
HO-1 reporter gene activity was markedly diminished by the
mutation, indicating that Nrf2 was involved at least in part
in the lansoprazole-induced HO-1 enhancer activity. Fur-
thermore, lansoprazole-induced reporter activity was dimin-
ished by the cotransfection of Keap1 or dominant-negative
Nrf2 expression plasmids (Fig. 6B). Together, these results
indicated that lansoprazole activates HO-1 enhancer activity
via Nrf2.
Lansoprazole-Induced MAPK Activation Contrib-
uted to the HO-1 Up-Regulation in RGM-1 Cells. Vari-
ous MAPKs have been reported to be involved in HO-1 up-
regulation (Elbirt et al., 1998). In this study, we tried to
identify the kinase involved in the lansoprazole-induced up-
regulation of HO-1 by Western blots using phosphorylation
status-dependent and -independent antibodies against p38,
ERK1/2 (44 and 42 kDa), and JNK kinases (54 and 46 kDa)
at 0, 5, 10, 30, and 60 min after lansoprazole treatment.
Western blots showed the phosphorylation of ERK in RGM-1
cells 5 min after lansoprazole treatment, but not that of p38
MAPK and JNK (Fig. 7A).
Moreover, RGM-1 cells were stimulated by lansoprazole in
the presence of a specific inhibitor for each of the MAPKs
(SP600125 for JNK, U01263 for ERK, and SB203580 for p38
MAPK) for 6 h. As shown in Fig. 7B, the inhibitor of ERK
(U01263), but not the inhibitors of the other two kinases (p38
MAPK and JNK), suppressed the up-regulation of HO-1 by
lansoprazole.
Identification of Phosphorylated Nrf2 Protein in
RGM-1 Cells Treated with Lansoprazole. To isolate
phosphorylated proteins from RGM-1 cell lysate, we used the
Pro-Q Diamond Phosphoprotein Enrichment kit. The cell
lysate (L fraction) was loaded on a column containing a
phosphoprotein-binding resin. The unphosphorylated pro-
teins were passed through the column (F fraction), and the
Fig. 4. The expression of HO-1 in
Nrf2(/) fibroblasts treated with
lansoprazole. Nrf2(/) and Nrf2(/)
fibroblasts were incubated with or
without lansoprazole (100 M) for 6 h.
The mRNA was extracted from the
cells, and the expression of HO-1
(A) was monitored using real-time
PCR. Values are the mean  S.E.M.
-fold change, considering 1 as the
value for Nrf2(/) fibroblasts with-
out lansoprazole. Furthermore, the
protein was also isolated, immuno-
blotted using anit-HO-1 antibody and
actin as internal control (B).
Fig. 5. Nuclear translocation and DNA-binding activity of Nrf2 in RGM-1
cells by lansoprazole stimulation. RGM-1 cells were treated with 10 M
lansoprazole for 2 h. Preparation of cell extracts and EMSA reactions
were carried out as described under Materials and Methods. The DNA-
protein complexes were observed (arrow), and the intensity of this band
was increased in a dose-dependent manner (A). Identification of StRE-
binding proteins was carried out by the supershift assay using anti-Nrf2
antibody (B). The complex band that increased with lansoprazole treat-
ment disappeared by the addition of anti-Nrf2 antibody (arrowhead).
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phosphorylated proteins were subsequently eluted (E frac-
tion). These proteins were precipitated from each fraction,
dissolved, and separated by SDS-PAGE. Then, the gel was
stained with Pro-Q Diamond phosphoprotein stain for the
detection of the phosphorylated proteins (Fig. 8A), followed
by Sypro ruby gel stain for the detection of total proteins (Fig.
8B).
Analysis by Pro-Q Diamond staining of SDS gels showed
the obvious increases in phosphorylated proteins in the E
fraction compared to the L or F fractions. Lansoprazole treat-
ment increased the phosphorylated proteins in the E fraction
detected by the Pro-Q Diamond staining (Fig. 8A). To detect
Nrf2 phosphorylation, the cell lysate and eluted proteins
were separated by SDS-PAGE and immunoblotted. The phos-
phorylated Nrf2 was increased in the E fraction of RGM-1
cells treated with lansoprazole. Thus, lansoprazole promoted
the phosphorylation of various proteins, and at least one of
these phosphorylated proteins was Nrf2.
Identification of Oxidation of the Keap1 Protein in
RGM-1 Cells Treated with Lansoprazole. To detect cel-
lular proteins that undergo cysteine-target oxidation by lan-
soprazole stimulation, biotin-cysteine was used as molecular
probe. This probe rapidly crosses the plasma membrane and
can be used to detect, quantify, purify, and identify proteins
Fig. 6. Lansoprazole activates HO-1 enhancer activity via Nrf2 in RGM-1 cells. A, wild-type or mutant HO-1 enhancer luciferase reporter plasmids
(100 ng) were transfected into RGM-1 cells and treated with lansoprazole for 12 h. Firefly luciferase activities were normalized with Renilla luciferase
activities expressed from a cotransfected pRL-TK plasmid. Luciferase activity treated with vehicle (dimethyl sulfoxide) in the absence of lansoprazole
was arbitrarily set as 100, and the mean values of at least five independent experiments are shown as relative luciferase units with the S.E.M. ,
significantly different from the activity of wild-type reporter-transfected cells in the same dose of lansoprazole (, p  0.01). B, wild-type HO-1
enhancer luciferase plasmids (100 ng) were transfected into RGM-1 cells in the presence of 50 M lansoprazole for 12 h together with either Keap1
expression vector, Nrf2 dominant-negative expression vector, or empty vector.  and , significantly different from the activity of empty vector-
transfected cells in the presence of 50 M lansoprazole (p  0.05, , p  0.01).
Fig. 7. Involvement of MAPK in the up-reg-
ulation of HO-1 by lansoprazole. A, the ex-
pression of p44/42, phosho-p44/42, p38,
phosho-p38, JNK, and phosho-JNK in
RGM-1 cells incubated with lansoprazole
was measured using Western blotting. B,
RGM-1 cells were treated by lansoprazole
with indicated concentrations of each inhibi-
tor (SP600125 for JNK, U01263 for ERK, and
SB203580 for p38 MAPK) for 6 h. The ex-
pression of HO-1 was monitored using West-
ern blotting.
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susceptible to oxidation in all compartments of cells (Ishii
and Uchida, 2004). RGM-1 cells exposed to biotin-cysteine
were treated with 10 M lansoprazole, and the biotin-cys-
teine-modified proteins were analyzed by Western blotting
with streptavidin-HRP. As shown in Fig. 9A, several proteins
were found to be S-oxidized in response to lansoprazole in a
dose-dependent manner. Moreover, the incorporation of bi-
otin-cysteine into endogenous Keap1 was confirmed by the
use of pull-down Streptavidin beads and  Columns followed
by Western blotting with an anti-Keap1 antibody. As shown
in Fig. 9B, the Keap1 protein was detected among the biotin-
cysteine-modified proteins, indicating that endogenous
Keap1 was oxidatively modified during the lansoprazole
stimulation.
Discussion
In the present study, we confirmed that lansoprazole in-
duced HO-1 up-regulation in rat gastric epithelial cells. In-
cubation with lansoprazole (1–100 M) induced expression of
the ho-1 gene in the early phase within 3 h of lansoprazole
addition. In association with the induction of ho-1 gene ex-
pression, the expression of the HO-1 protein was signifi-
cantly increased in a time- and dose-dependent manner after
lansoprazole treatment, and confocal microscopy revealed
that the HO-1 protein was localized to the cytoplasm fraction.
In this study, we could not observe HO-1 up-regulation in-
duced by other anti-acid secretory agents such as omeprazole
and famotidine. Although Becker et al. (2006) demonstrated
that omeprazole as well as lansoprazole induced the expres-
sion of HO-1 on gastric epithelial cells, this effect might be
based on the high concentration of omeprazole (300 M) that
they administrated.
To investigate the contribution of lansoprazole-induced
HO-1 up-regulation to chemokine production by RGM-1 cells,
we measured whether the production of CINC-1 induced by
Fig. 8. The phosphorylation of protein
in RGM-1 cells treated with lansopra-
zole. Lansoprazole-treated RGM-1
cells lysates (L), flow-through (F), and
eluates (E) were obtained using the
Pro-Q Diamond Phosphoprotein En-
richment kit. Proteins were precipi-
tated from each fraction and dis-
solved, separated by SDS-PAGE. The
gel was stained with Sypro ruby gel
stain for the detection of total proteins
(A) and subsequently Pro-Q Diamond
phosphoprotein stain for the detection
of the phosphorylated proteins (B).
Furthermore, to detect the phosphor-
ylation of Nrf2 in RGM-1 cells by lan-
soprazole, the cell lysates and eluates
were immunoblotted using anti-Nrf2
antibody (C).
Fig. 9. The detection and identification of S-oxidized proteins in RGM-1
cells exposed to lansoprazole. A, biotin-cysteine-protein adducts were
detected by Western blotting. RGM-1 cells were incubated with 100 M
biotin-cysteine for 15 min and then treated with 10 M lansoprazole for
45 min. Total cell lysate was separated by 10% SDS-PAGE followed by
immunoblotting analysis. B, to isolate the biotin-cysteine-modified pro-
tein, the cell lysates were mixed with Streptavidin MicroBeads, and
subsequently the MicromBeads-labeled proteins were separated using 
Columns. The collected samples were analyzed by Western blotting using
anti-Keap1 antibody.
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IL-1 was inhibited by lansoprazole. CINC-1, a counterpart
of the human GRO (a member of IL-8 family), has been
suggested to play a critical role as a mediator of neutrophil
infiltration in rats during inflammation. Pretreatment with
lansoprazole significantly inhibited the production of CINC-1
from stimulated RGM-1 cells. In addition, the inhibition was
reversed by cotreatment with the HO-1 inhibitor SnPP.
These data indicate that the anti-inflammatory effect of lan-
soprazole is mediated through the induction of HO-1.
For the mechanism of lansoprazole-induced up-regulation
of HO-1, we have shown using an siRNA approach and Nrf2-
deficient fibroblasts that the transcriptional factor Nrf2
plays a critical role in the up-regulation of HO-1 in RGM-1
cells. The treatment of RGM-1 cells with Nrf2-siRNA de-
creased the constitutive ho-1 mRNA level and abolished the
lansoprazole-induced ho-1 mRNA and HO-1 protein expres-
sion, suggesting that Nrf2 plays a pivotal role in the regula-
tion of HO-1 in RGM-1 cells. The involvement of Nrf2 in the
HO-1 up-regulation induced by lansoprazole was also con-
firmed by the findings obtained from Nrf2-deficient fibro-
blasts. The expression of ho-1 mRNA and HO-1 protein was
faint in Nrf2-deficient fibroblasts with or without lansopra-
zole incubation.
Extensive analysis has identified a common mechanism
involving the StRE/Nrf2 transcription factor pathway for
gene regulation in response to a diverse array of HO-1 induc-
ers (He et al., 2001; Alam et al., 2003; Gong et al., 2003;
Massrieh et al., 2006). The StREs mediate transcriptional
activation in response to multiple agents, including heme,
heavy metals, TPA, arsenite, hydrogen peroxide, hyperoxia,
LPS, and various electrophiles (Choi and Alam, 1996). These
motifs in StRE are targets for multiple members of the basic-
leucine zipper (bZIP) superfamily of sequence-specific DNA-
binding proteins, including the AP-1, cAMP response ele-
ment-binding protein/ATF, Maf, and CNC-bZIP classes of
transcription factors. Alam et al. (1999) have also described
that the induction of HO-1 by StREs in L929 fibroblasts
demonstrated potent trans-activation of the E1 enhancer by
CNC-bZIP factors, particularly Nrf2. In this study, EMSA
reactions using nuclear protein fractions from RGM-1 cells
were carried out to identify DNA-binding proteins potentially
responsible for lansoprazole-mediated ho-1 up-regulation.
Lansoprazole treatment of RGM-1 cells significantly in-
creased the levels of the StRE-protein complex in a concen-
tration-dependent manner. In addition, the increased com-
plex band disappeared after the addition of anti-Nrf2
polyclonal antibody. These data indicate that activation of
the ho-1 gene by lansoprazole occurs, at least in part, as a
consequence of increased binding of Nrf2 to the StREs. More-
over, in a luciferase reporter assay using HO-1 enhancer-
luciferase reporter gene containing mutant StREs, lansopra-
zole-induced HO-1 reporter gene activity was markedly
decreased by the mutation. On the other hand, lansoprazole-
induced reporter activity was also diminished by the cotrans-
fection of dominant-negative Nrf2 expression plasmids. To-
gether, these results confirm that lansoprazole activates
HO-1 enhancer activity via Nrf2.
Multiple protein kinase pathways, such as MAPK, protein
kinase C, and p38 MAPK, have been proposed to play a role
in HO-1 induction. The present study demonstrated that
lansoprazole promoted the phosphorylation of ERK, but not
that of p38 MAPK or JNK in RGM-1 cells, and that lanso-
prazole-induced HO-1 up-regulation was suppressed by
U01263, a specific inhibitor for ERK. These data indicate
that HO-1 up-regulation by lansoprazole was at least partly
mediated by the ERK pathway. The role of the ERK pathway
in the induction of HO-1 is controversial; ERK has been
found to regulate HO-1 expression in some studies (Gong et
al., 2003; Schwer et al., 2008) but not in others (Ning et al.,
2002). This discrepancy may reflect cell type- and/or species-
specific differences in the regulatory mechanism of HO-1.
It has recently been described that phosphorylated forms
of Nrf2 modified after chemically induced oxidative stress
play a potential role in Nrf2 activation and degradation (Pi et
al., 2007). Furthermore, electrophilic- or reactive oxygen spe-
cies-induced nuclear Nrf2 accumulation is shown to be highly
dependent on protein kinase CK2 activity. In this study, the
detection of phosphorylated protein was assayed using Pro-Q
Diamond phosphoprotein stain. Consequently, the phospho-
proteins in RGM-1 cells were markedly increased by treat-
ment with lansoprazole. The purification of these phospho-
proteins induced by lansoprazole was performed using a
Pro-Q Diamond Phosphoprotein Enrichment kit, and Nrf2
was clearly detected in the purified phosphoproteins. The
increased phosphorylated forms of Nrf2 might play a role in
its activation or nuclear accumulation.
Keap1 is rich in cysteine residues, and this fact has indi-
cated that Keap1 is a sensor protein of xenobiotic and oxida-
tive stress. Early studies proposed that Keap1 oxidation re-
leased Nrf2, allowing it to enter the nucleus and bind to
antioxidant-response element-containing genes (Dhakshi-
namoorthy and Jaiswal, 2001; Itoh et al., 2003). In agree-
ment with these studies, in vitro oxidation of Keap1 has been
shown to cause a change in the affinity of Keap1 for the Neh2
domain, releasing Nrf2 (Dinkova-Kostova et al., 2002). Re-
cent in vivo studies have reported that oxidation does release
the Nrf2/Keap1 complex (Zhang and Hannink, 2003). In the
present study, lansoprazole promoted the oxidized protein in
a dose-dependent manner. Like Ishi and Uchida (2004) and
Sakurai et al. (2006), we used biotin-cysteine as a probe in
our investigation of cysteine-targeted oxidation of proteins.
Fig. 10. Lansoprazole exerts anti-inflammatory effect through the up-
regulation of HO-1 expression in rat gastric epithelial cells. Phosphory-
lation of ERK and Nrf2, activation and nuclear translocation of Nrf2, and
oxidation of Keap1 are all involved in the lansoprazole-induced HO-1
up-regulation.
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We also purified and blotted the oxidized proteins and con-
firmed the existence of Keap1 in these oxidized proteins.
In summary, our data showed that lansoprazole up-regu-
lated HO-1 expression in rat gastric epithelial cells, and the
up-regulated HO-1 had anti-inflammatory effects. It appears
that lansoprazole-induced HO-1 production is mediated by
the activation, phosphorylation, and nuclear translocation of
Nrf2 in accompaniment with the dissection of oxidized Keap1
(Fig. 10). Further studies will be needed to clarify the mech-
anisms involved in this phenomenon in greater detail.
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